Dr. Richard Enmon
studied biomedical and chemical engineering at Tulane University in New Orleans, Louisiana, earning his doctoral degree in 2000. During his graduate studies he combined his engineering background with molecular biology, investigating mathematical models of cancer cell activity, in particular, relating to tumor formation and metastatic conversion. He continued his studies of metastatic and disseminated cancers as a post-doctoral research fellow in nuclear science at Memorial Sloan-Kettering Cancer Center in New York, New York, specializing in the development of immunoconjugated-radionuclide therapies. Developing an interest in the protection of intellectual property, he enrolled in Fordham University School of Law, earning a J.D. in 2008. Dr. Enmon was registered before the United States Patent and Trademark Office as a patent agent in 2003 and as an attorney in 2009. From 2003 until 2009, his practice focused on the drafting and prosecution of U.S. patent applications in the fields of biopharmaceuticals, small molecules and medical devices. He also has extensive experience in the preparation of validity, non-infringement, inventorship and freedom-to-operate opinions based on U.S. patent law and practice. Dr. Enmon joined the firm Vossius & Partner in 2009 and was registered as a European Patent Attorney in 2013.